Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q3 2022 to Q4 2022
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 15
- Est. +$8.31M
- Added
- 22
- Est. +$8.23M
- Reduced
- 35
- Est. −$28.4M
- Sold out
- 6
- Est. −$753.0K
Portfolio value went from $187.8M to $187.7M (−$119.3K (−0.1%)); positions from 66 to 75 (+9).
All Q4 2022 holdingsAll Q3 2022 holdings
In the shares, value and % of portfolio columns, the top figure is Q4 2022 and the gray one below is Q3 2022. For stocks that split between the two quarters, Q3 2022 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| Achilles Therapeutics PLC00449L102 | Reduced– | 30,52532,200 | −1,675−5.2% | $27.5K$72.0K | −$1.51K | <0.1%<0.1% | −0.02 |
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 24,78747,869 | −23,082−48.2% | $39.7K$71.0K | −$36.9K | <0.1%<0.1% | −0.02 |
| SURFSurface Oncology, Inc. | ReducedHistory | 63,35666,838 | −3,482−5.2% | $52.0K$70.0K | −$2.86K | <0.1%<0.1% | −0.01 |
| JSPRJasper Therapeutics, Inc. | ReducedHistory | 114,000119,800 | −5,800−4.8% | $55.1K$94.0K | −$2.80K | <0.1%0.1% | −0.02 |
| MREOMereo BioPharma Group plc | ReducedHistory | 73,500112,800 | −39,300−34.8% | $55.1K$96.0K | −$29.5K | <0.1%0.1% | −0.02 |
| ANNXAnnexon, Inc. | ReducedHistory | 15,45616,055 | −599−3.7% | $79.9K$98.0K | −$3.10K | <0.1%0.1% | −0.01 |
| PSTXPoseida Therapeutics, Inc. | ReducedHistory | 15,27015,650 | −380−2.4% | $80.9K$59.0K | −$2.01K | <0.1%<0.1% | +0.01 |
| REGNRegeneron Pharmaceuticals, Inc. | ReducedHistory | 307315 | −8−2.5% | $221.5K$216.0K | −$5.77K | 0.1%0.1% | 0.00 |
| UNHUnitedHealth Group Inc | ReducedHistory | 524662 | −138−20.8% | $279.3K$339.0K | −$73.6K | 0.1%0.2% | −0.03 |
| PFEPfizer Inc | ReducedHistory | 6,3877,574 | −1,187−15.7% | $327.3K$329.0K | −$60.8K | 0.2%0.2% | 0.00 |
| SPDR Series Trust78468R622 | Reduced– | 4,1375,126 | −989−19.3% | $372.3K$450.0K | −$89.0K | 0.2%0.2% | −0.04 |
| Tidal ETF Tr886364603 | Reduced– | 35,13251,077 | −15,945−31.2% | $654.5K$877.0K | −$297.1K | 0.3%0.5% | −0.12 |
| iShares MSCI USA Min Vol Factor ETF46429B697 | Reduced– | 12,27014,207 | −1,937−13.6% | $884.6K$941.0K | −$139.6K | 0.5%0.5% | −0.03 |
| DJPBarclays Bank PLC | ReducedHistory | 47,62252,787 | −5,165−9.8% | $1.61M$1.73M | −$174.1K | 0.9%0.9% | −0.07 |
| Vanguard Total International Bond ETF92203J407 | Reduced– | 36,97144,084 | −7,113−16.1% | $1.75M$2.10M | −$337.4K | 0.9%1.1% | −0.19 |
| iShares Tr464288588 | Reduced– | 20,24621,860 | −1,614−7.4% | $1.88M$2.00M | −$149.7K | 1.0%1.1% | −0.07 |
| WisdomTree Tr97717W562 | Reduced– | 44,09056,188 | −12,098−21.5% | $1.88M$2.20M | −$515.3K | 1.0%1.2% | −0.17 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 14,15515,946 | −1,791−11.2% | $1.99M$1.97M | −$251.5K | 1.1%1.0% | +0.01 |
| iShares Tr464288661 | Reduced– | 19,35021,223 | −1,873−8.8% | $2.22M$2.43M | −$215.2K | 1.2%1.3% | −0.11 |
| iShares Inc46434G509 | Reduced– | 108,719323,537 | −214,818−66.4% | $2.49M$7.41M | −$4.93M | 1.3%3.9% | −2.62 |
| iShares Tr464287440 | Reduced– | 26,17429,289 | −3,115−10.6% | $2.51M$2.81M | −$298.4K | 1.3%1.5% | −0.16 |
| Invesco Exch Traded FD Tr II46138G508 | Reduced– | 126,387150,077 | −23,690−15.8% | $2.59M$3.03M | −$486.4K | 1.4%1.6% | −0.23 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Reduced– | 28,34436,920 | −8,576−23.2% | $2.99M$3.79M | −$904.3K | 1.6%2.0% | −0.43 |
| iShares Tr464288281 | Reduced– | 36,57247,679 | −11,107−23.3% | $3.09M$3.78M | −$939.6K | 1.6%2.0% | −0.36 |
| Vanguard Intl Equity Index F922042676 | Reduced– | 96,701112,258 | −15,557−13.9% | $4.00M$4.28M | −$643.1K | 2.1%2.3% | −0.15 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 11,65516,430 | −4,775−29.1% | $4.48M$5.90M | −$1.83M | 2.4%3.1% | −0.76 |
| Vanguard Real Estate ETF922908553 | Reduced– | 58,32372,739 | −14,416−19.8% | $4.81M$5.83M | −$1.19M | 2.6%3.1% | −0.54 |
| Vanguard World FD921910709 | Reduced– | 62,10475,712 | −13,608−18.0% | $5.14M$6.56M | −$1.13M | 2.7%3.5% | −0.75 |
| SPDR Series Trust78464A490 | Reduced– | 139,953156,030 | −16,077−10.3% | $5.77M$6.24M | −$662.4K | 3.1%3.3% | −0.25 |
| First Tr Exchange-Traded FD33738D101 | Reduced– | 256,890265,120 | −8,230−3.1% | $6.86M$6.60M | −$219.7K | 3.7%3.5% | +0.14 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 75,97788,668 | −12,691−14.3% | $7.92M$8.10M | −$1.32M | 4.2%4.3% | −0.09 |
| iShares Tr464288372 | Reduced– | 180,646196,459 | −15,813−8.0% | $8.28M$8.22M | −$724.9K | 4.4%4.4% | +0.03 |
| PIMCO ETF Tr72201R304 | Reduced– | 187,911205,507 | −17,596−8.6% | $10.9M$11.5M | −$1.02M | 5.8%6.1% | −0.30 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 106,394132,581 | −26,187−19.8% | $15.5M$17.4M | −$3.82M | 8.3%9.3% | −0.99 |
| Nushares ETF Tr67092P300 | Reduced– | 652,028824,875 | −172,847−21.0% | $22.3M$25.5M | −$5.92M | 11.9%13.6% | −1.66 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.